In the intricate world of pharmaceutical manufacturing, the quality and availability of Active Pharmaceutical Ingredient (API) intermediates are foundational. Canagliflozin, with CAS number 842133-18-0, represents such a critical compound, playing a significant role in the development of treatments for type 2 diabetes. As a specialized chemical supplier, we aim to demystify the aspects of this important intermediate.

Canagliflozin is characterized by its molecular formula C24H25FO5S and a molecular weight of approximately 444.52. It is typically supplied as a white powder, and its primary application lies in its function as a selective SGLT-2 inhibitor. This pharmacological action makes it an indispensable component in the synthesis of drugs aimed at managing blood glucose levels. For researchers and manufacturers looking to buy Canagliflozin pharmaceutical intermediate, understanding these properties is essential for ensuring successful synthesis outcomes.

The global supply chain for pharmaceutical intermediates relies heavily on specialized manufacturers. Identifying a dependable Canagliflozin CAS 842133-18-0 supplier, particularly one based in China, can provide a significant advantage in terms of cost-effectiveness and scale of production. A premier Canagliflozin manufacturer in China will offer high-purity products, often exceeding 99%, backed by comprehensive analytical data and robust quality control systems.

For procurement professionals tasked with sourcing materials to purchase 444.52 molecular weight pharmaceutical intermediate, a direct relationship with manufacturers is often the most efficient route. This allows for direct inquiries about product availability, pricing, and customization options. The ability to get a quick quote and understand the supplier's production capacity for Canagliflozin ensures that project timelines are met consistently.

In summary, Canagliflozin (CAS 842133-18-0) is more than just a chemical compound; it is a vital link in the chain of pharmaceutical innovation. By partnering with experienced Chinese manufacturers and suppliers, companies can secure the high-quality intermediates needed to bring advanced therapeutic solutions to market.